Publications by authors named "Laura De Ferrari"

Claim this Profile
E
Expression of human Interferon Regulatory Factor 3 (IRF-3) in alveolar macrophages relates to clinical and functional traits in COPD.
Simonetta Baraldo, Matteo Bonato, Sebastiano Cassia, Paolo Casolari, Laura De Ferrari

Respir Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thymic Stromal Lymphopoietin and Tezepelumab in Airway Diseases: From Physiological Role to Target Therapy.
Diego Bagnasco, Laura De Ferrari, Benedetta Bondi, Maria Giulia Candeliere, Marcello Mincarini

Int J Mol Sci· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moderate asthma: burden, mechanisms and therapeutic perspectives.
Laura De Ferrari, Anna Maria Riccio, Fulvio Braido

Curr Opin Allergy Clin Immunol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders.
Diego Bagnasco, Stefania Nicola, Elisa Testino, Luisa Brussino, Laura Pini, Laura De Ferrari

Biomedicines· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nasal cytology as a reliable non-invasive procedure to phenotype patients with type 2 chronic rhinosinusitis with nasal polyps.
Giovanni Paoletti, Luca Malvezzi, Anna Maria Riccio, Desideria Descalzi, Francesca Pirola, Laura De Ferrari

World Allergy Organ J· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe asthma: One disease and multiple definitions.
Diego Bagnasco, Pierluigi Paggiaro, Manuela Latorre, Chiara Folli, Elisa Testino, Laura De Ferrari

World Allergy Organ J· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vitro Reduction of Interleukin-8 Response to by Strains Isolated from the Same Polymicrobial Urines.
Gabriella Piatti, Laura De Ferrari, Anna Maria Schito, Anna Maria Riccio, Susanna Penco

Microorganisms· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Benralizumab in severe asthma in real life and focus on nasal polyposis.
Diego Bagnasco, Luisa Brussino, Marco Bonavia, Elisa Calzolari, Marco Caminati, Laura De Ferrari

Respir Med· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do the current guidelines for asthma pharmacotherapy encourage over-treatment?
Diego Bagnasco, Luisa Brussino, Cristiano Caruso, Giovanni Paoletti, Enrico Heffler, Laura De Ferrari

Expert Opin Pharmacother· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The importance of being not significant: Blood eosinophils and clinical responses do not correlate in severe asthma patients treated with mepolizumab in real life.
Diego Bagnasco, Alessandro Massolo, Marco Bonavia, Luisa Brussino, Caterina Bucca, Laura De Ferrari

Allergy· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving phenotypes to endotypes: is precision medicine achievable in asthma?
Diego Bagnasco, Giovanni Passalacqua, Marco Caminati, Enrico Heffler, Francesco Menzella, Laura De Ferrari

Expert Rev Respir Med· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma Galectin-3 and urine proteomics predict FEV improvement in omalizumab-treated patients with severe allergic asthma: Results from the PROXIMA sub-study.
Anna Maria Riccio, Pierluigi Mauri, Laura De Ferrari, Rossana Rossi, Dario Di Silvestre

World Allergy Organ J· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Galectin-3: an early predictive biomarker of modulation of airway remodeling in patients with severe asthma treated with omalizumab for 36 months.
Anna Maria Riccio, Pierluigi Mauri, Laura De Ferrari, Rossana Rossi, Dario Di Silvestre

Clin Transl Allergy· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular diagnosis and precision medicine in allergy management.
Anna Maria Riccio, Laura De Ferrari, Alessandra Chiappori, Sabina Ledda, Giovanni Passalacqua

Clin Chem Lab Med· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular phenotyping and biomarker development: are we on our way towards targeted therapy for severe asthma?
Laura De Ferrari, Alessandra Chiappori, Diego Bagnasco, Anna Maria Riccio, Giovanni Passalacqua

Expert Rev Respir Med· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD4(+)CD25(high)CD127(-) regulatory T-cells in COPD: smoke and drugs effect.
Alessandra Chiappori, Chiara Folli, Francesco Balbi, Emanuela Caci, Anna Maria Riccio, Laura De Ferrari

World Allergy Organ J· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers and severe asthma: a critical appraisal.
Alessandra Chiappori, Laura De Ferrari, Chiara Folli, Pierluigi Mauri, Anna Maria Riccio

Clin Mol Allergy· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venom immunotherapy in patients with clonal mast cell disorders: efficacy, safety, and practical considerations.
Patrizia Bonadonna, David Gonzalez-de-Olano, Roberta Zanotti, Annamaria Riccio, Laura De Ferrari

J Allergy Clin Immunol Pract· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomics of bronchial biopsies: galectin-3 as a predictive biomarker of airway remodelling modulation in omalizumab-treated severe asthma patients.
Pierluigi Mauri, Anna Maria Riccio, Rossana Rossi, Dario Di Silvestre, Louise Benazzi, Laura De Ferrari

Immunol Lett· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis